CDT Equity Inc.
CDT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001896212
In the last 90 days, CDT Equity Inc. insiders filed 0 open-market purchases and 1 sale; 8 institutions reported holding it in 13F filings for Q2 2026, worth $94.7K in total; no superinvestor holds it.
Other share classesCDTTW
Holders of 5% or more of CDT
Holders whose latest Schedule 13D or 13G filing reports 5% or more of CDT Equity Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Taylor Mark Andrew | 13D | 43.79%51.7M shares | New | Mar 30, 20261 filing | Mar 30, 2026 | SEC |
| Corvus Capital Ltd. | 13D/A | 19.10%386.7K shares | +5.80 ppfrom 13.30% | Jul 31, 20253 filings | Dec 22, 2025 | SEC |
| Ascent Partners Fund LLC | 13G | 9.90%543.6K shares | 0.00 ppfrom 9.90% | Feb 18, 20262 filings | Jun 5, 2026 | SEC |
| A.G.P. / Alliance Global Partners, LLC | 13G | 9.80%1.11M shares | New | May 15, 20251 filing | May 15, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
13 Schedule 13D and 13G filings on CDT Equity Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Jun 23, 20266:42 PM ET | Taylor Mark Andrewand 2 others | 13D/A | 0.00%0 shares | –Below 5% | Jun 18, 2026 | SEC |
| Jun 5, 20268:51 PM ET | Ascent Partners Fund LLCand 9 others | 13G | 9.90%543.6K shares | 0.00 ppfrom 9.90% | Jun 1, 2026 | SEC |
| Mar 30, 20269:21 PM ET | Taylor Mark Andrewand 2 others | 13D | 43.79%51.7M shares | New | Feb 19, 2026 | SEC |
| Feb 18, 20266:26 PM ET | Ascent Partners Fund LLCand 8 others | 13G | 9.90%255.7K shares | New | Feb 17, 2026 | SEC |
| Dec 22, 20254:05 PM ET | Corvus Capital Ltd.and 1 other | 13D/A | 19.10%386.7K shares | +5.80 ppfrom 13.30% | Dec 8, 2025 | SEC |
| Sep 22, 20255:56 PM ET | Corvus Capital Ltd.and 3 others | 13D/A | 13.30%1.29M shares | +7.30 ppfrom 6.00% | Sep 19, 2025 | SEC |
| Aug 18, 20254:42 PM ET | Sarborg Ltd | 13G/A | 4.00%123.6K shares | −12.40 ppfrom 16.40%Below 5% | Jul 8, 2025 | SEC |
| Jul 31, 20257:46 PM ET | Corvus Capital Ltd.and 3 others | 13D/A | 6.00%175.0K shares | – | Jun 3, 2025 | SEC |
| May 15, 20254:18 PM ET | A.G.P. / Alliance Global Partners, LLCand 5 others | 13G | 9.80%1.11M shares | New | Mar 31, 2025 | SEC |
| May 7, 20255:36 PM ET | Sarborg Ltd | 13G | 16.40%1.85M shares | New | Mar 31, 2025 | SEC |
| Apr 10, 20256:00 AM ET | AstraZeneca PLCand 1 other | 13G/A | 1.10%73.9K shares | –Below 5% | Mar 31, 2025 | SEC |
| Feb 20, 20254:32 PM ET | Nirland Ltdand 3 others | 13G/A | 0.00%0 shares | −9.98 ppfrom 9.98%Below 5% | Feb 19, 2025 | SEC |
| Jan 21, 20255:00 PM ET | Nirland Ltdand 3 others | 13G | 9.98%15.3M shares | New | Jan 13, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell CDT Equity Inc. shares.
No Form 144 notices for CDT Equity Inc. are on file.